RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Eric Otto Johnson

Eric Otto Johnson

Distinguished Fellow, Epidemiology


Postdoctoral fellowships in epidemiology (Johns Hopkins University) and genetics (National Institute on Drug Abuse)
PhD, Sociology, Western Michigan University
MA, Sociology, Western Michigan University
BA, Sociology and Psychology, Olivet Nazarene University


Eric Otto Johnson, Ph.D., has more than 20 years of experience studying the epidemiology and genetics of drug addiction, HIV, and related phenotypes. He has published more than 130 peer-reviewed articles. 

Dr. Johnson has been the Principal Investigator of 12 National Institutes of Health (NIH)-funded studies. His current research focuses on multi-omics approaches to understanding the biological drivers of drug addiction and the biological consequences of drug exposure across a number of substances (e.g., opioids, cocaine, and nicotine), including in the context of living with HIV. Other areas of interest include analytical methods development and epigenetic epidemiology – using DNA methylation to measure exposures from the environment. 

He is the former Chair of the Behavioral Genetics and Epidemiology Study Section and has chaired and served on numerous other NIH review and advisory panels.

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics